Fig. 1
From: Bevacizumab treatment of meningeal melanoma metastases
Tumor growth and host survival. a Histological preparations of brains from untreated and bevacizumab-treated mice showing that A-07 and D-12 cells developed meningeal tumors after intracranial cell inoculation. The day numbers indicate time after cell inoculation. b Fraction of surviving mice versus time after cell inoculation for untreated and bevacizumab-treated mice with meningeal A-07 or D-12 tumors (N = 10 in each group). Bevacizumab treatment prolonged the survival of mice with A-07 tumors but not the survival of mice with D-12 tumors. P-values: log-rank test